Market Chatter: IMBiologics Signs $964 Million Licensing Deal for Autoimmune Treatments
Market Chatter: IMBiologics Signs $964 Million Licensing Deal for Autoimmune Treatments
市场传闻：IMBiologics签署了9.64亿美元的自身免疫性治疗授权协议。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册